6 December 2021 in Frontiers in Psychiatry
Background: Medical students are not spared from the challenges related to the Covid-19 lockdown. The fear and uncertainties may lead to traumatic symptoms and test their resilience and sense of coping. Thus, this study aims to determine the prevalence of peri-traumatic distress symptoms and its association with the level of resilience and the coping strategies used during the lockdown among medical students.Materials and Methods: This was a cross-sectional online questionnaire survey involving medical students from a public university in Malaysia. It was conducted during the COVID-19 lockdown or Movement Control Order (MCO) where the students were asked to fill in the COVID-19 Peri-traumatic Distress Index (CPDI), Brief COPE Inventory, and Connor Davidson Resilience Scale (CDRS-25).Results: A total of 282 clinical and 172 pre-clinical medical students were involved. Peri-traumatic distress symptoms were reported by 27% out of the total students. This study found that those who were having peritraumatic distress symptoms were from the pre-clinical years, had poor internet access, as well as lower resilience levels, and used more dysfunctional coping strategies. Pre-clinical medical students with difficult internet access were eight times more likely to have peritraumatic distress symptoms.Conclusions: Given the high level of peri-traumatic distress symptoms reported by medical students during the lockdown, it is vital to identify the vulnerable students, assess their needs and risks to mental health problems during this challenging time as the pandemic is still ongoing with countries going in and out of lockdown depending on the cases at the time. The university administration for each University in Malaysia will need to have a clear academic guideline and policy as well as providing improved infrastructure to minimize the distress faced by medical students.
13 March 2024 in Special Care in Dentistry
RRRaja Nur Adilah Raja Abdul Rahman
Raja Nur Adilah Raja Abdul Rahman
NRNawwal Alwani Mohd Radzi
31 December 2024 in East Asian Archives of Psychiatry
East Asian Arch Psychiatry 2024;34:91-102 | https://doi.org/10.12809/eaap2426 ORIGINAL ARTICLE Factors associated with attention deficit hyperactivity...
22 June 2026 in Middle East Current Psychiatry
Background: In Malaysia, there is a gap between the rising prevalence of mental disorder and limited specialist resources. Mobile mental health (mHealth) apps have a potential to address the issue, but it is still uncertain how different diagnostic profile – GAD and MDD perceive and utilise the tools. This study examined awareness and attitudes towards mental illness and digital readiness between MDD and GAD patients. Methods: A cross-sectional study design was used to examine baseline data from a pilot Randomised Controlled Trial conducted at the psychiatric clinic in Hospital Al-Sultan Abdullah (HASA), UiTM. 74 participants (38 with MDD and 36 with GAD) were recruited through consecutive sampling. Sociodemographic questionnaires, the PHQ-9, the GAD-7, and a validated mHealth application awareness and attitudes survey were administered. Chi-square and Fisher’s exact tests were used to determine differences in app usage and perceived barriers. Results: Smartphone ownership was ubiquitous (100%), and over 88% in both groups were willing to adopt mHealth apps. However, the actual engagement in application use differed: GAD subjects were more likely to use mindfulness apps than MDD (50.0% versus 26.3%, P = 0.036). With respect to barriers, concern about privacy was more often present in GAD patients (66.7%) than MDD patients (44.7%) ( P = 0.058). Although there was strong interest in the use of mHealth app, more than 60% of patients did not know where to find suitable apps for mental health intervention. Conclusions: Although both cohorts are digitally literate and open to mHealth adoption, barriers to adoption are diagnoses-specific. Patients with MDD appears limited in using self-monitoring application due to motivational deficit related to their symptom severity, while fear of data exposure is the major source of barriers in GAD patients. Thus, a ‘one-size-fits-all’ approach may be insufficient, hence the need for a clinician-guided digital prescription to address the issue.